LOS ANGELES, CA - September 29, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) is positioned amid limitations of traditional 12-lead electrocardiogram ("ECG") systems, often including cumbersome ...
LOS ANGELES, CA - September 11, 2025 (NEWMEDIAWIRE) - For decades, the traditional 12-lead electrocardiogram ("ECG") has been the gold standard in cardiac diagnostics, including arrhythmia assessment, ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack ...
To treat a persistent arrhythmia, surgeons need to know more than just that the heart’s beats are out of sync—they need a map of the cardiac muscle’s electrical activity to see exactly where things ...
HeartBeam BEAT announced it has received FDA 510(k) clearance for its flagship ECG system, a first-of-its-kind, credit card-sized, cable-free device designed to deliver high-fidelity, ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results